Smad4 promotes diabetic nephropathy by modulating glycolysis and OXPHOS.
Li J, Sun YBY, Chen W, Fan J, Li S, Qu X, Chen Q, Chen R, Zhu D, Zhang J, Wu Z, Chi H, Crawford S, Oorschot V, Puelles VG, Kerr PG, Ren Y, Nilsson SK, Christian M, Tang H, Chen W, Bertram JF, Nikolic-Paterson DJ, Yu X.
Li J, et al. Among authors: crawford s.
EMBO Rep. 2020 Feb 5;21(2):e48781. doi: 10.15252/embr.201948781. Epub 2020 Jan 9.
EMBO Rep. 2020.
PMID: 31916354
Free PMC article.